Variant report

Variant	nsv879606
Chromosome Location	chr4:93391251-93479275
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:6)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:93384358..93386319-chr4:93419609..93421147,2	K562	blood:
2	chr4:93404272..93405260-chr4:93422586..93423310,3	MCF-7	breast:
3	chr4:93404272..93404961-chr4:93422474..93423086,2	MCF-7	breast:
4	chr4:93404272..93404961-chr4:93422474..93423086,2	MCF-7	breast:
5	chr4:93434886..93436541-chr4:93486388..93487907,2	MCF-7	breast:
6	chr4:93404272..93405260-chr4:93422586..93423310,3	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RP11-9B6.1.1-4	chr4:93409417-93409530	ucscGeneNc_uc010ikw_1
2	lnc-RP11-9B6.1.1-4	chr4:93402672-93403529	ucscGeneNc_uc010ikw_1
3	lnc-RP11-9B6.1.1-4	chr4:93417224-93417476	ucscGeneNc_uc010ikw_1

No data

Extended variants
information (count: 3335 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:3335 , 50 per page) page: 1 2 3 4 5 6 7 ... 67

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6856342	chr4:93391251-93391252	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs536812747	chr4:93391272-93391273	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs369100961	chr4:93391380-93391381	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs576479878	chr4:93391407-93391408	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs563662856	chr4:93391412-93391413	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs79865969	chr4:93391413-93391414	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs576658388	chr4:93391430-93391431	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs186428251	chr4:93391435-93391436	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs148903099	chr4:93391463-93391464	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs143580583	chr4:93391473-93391474	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs541197012	chr4:93391498-93391499	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs35158685	chr4:93391501-93391502	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs190344233	chr4:93391613-93391614	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs114748746	chr4:93391615-93391616	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs372112590	chr4:93391621-93391622	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs148040618	chr4:93391638-93391639	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs116660386	chr4:93391639-93391640	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs555137532	chr4:93391656-93391657	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs532001135	chr4:93391682-93391683	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs73837304	chr4:93391700-93391701	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs141725765	chr4:93391760-93391761	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs535054971	chr4:93391815-93391816	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs555136090	chr4:93391841-93391842	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs568570756	chr4:93391843-93391844	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs573704781	chr4:93391872-93391873	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs12645728	chr4:93391877-93391878	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs557514468	chr4:93391957-93391958	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs577277756	chr4:93391983-93391984	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs546206629	chr4:93391992-93391993	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs556161317	chr4:93392014-93392015	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs553434181	chr4:93392024-93392025	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs183687363	chr4:93392054-93392055	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs541005428	chr4:93392083-93392084	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs561093526	chr4:93392136-93392137	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs201709944	chr4:93392147-93392148	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs187866200	chr4:93392148-93392149	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs544928695	chr4:93392150-93392151	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs563059051	chr4:93392162-93392163	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs532109747	chr4:93392174-93392175	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs559898509	chr4:93392221-93392222	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs147071743	chr4:93392278-93392279	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs111368129	chr4:93392286-93392287	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs565378545	chr4:93392296-93392297	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs542828183	chr4:93392335-93392336	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs375903773	chr4:93392346-93392347	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs192942489	chr4:93392387-93392388	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs528742634	chr4:93392394-93392395	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs543902255	chr4:93392411-93392412	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs138387712	chr4:93392444-93392445	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs537266279	chr4:93392464-93392465	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Autism	18414403	CNVD
primary effusion lymphomas	17116491	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Olfactory neuroblastoma	18408657	CNVD
small cell lung cancer	20016488	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
Colorectal cancer	20459617	CNVD
Acute monocytic leukemia	16498392	CNVD
Multiple myeloma	16616336	CNVD
Esophageal adenocarcinoma	18820669	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myelofibrosis	22110671	CNVD
Parkinson disease	20877625	CNVD
Hirschsprung''s Disease	21712996	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	20164920	CNVD
Cancer	20164919	CNVD
Esophageal cancer	21851588	CNVD
Cancer	19907438	CNVD
Williams Syndrome	20824207	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:93376800-93396600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr4:93377000-93403400	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr4:93384800-93392400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
4	chr4:93385600-93393600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
5	chr4:93386400-93392200	Weak transcription	H1 Cell Line	embryonic stem cell
6	chr4:93388000-93395400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
7	chr4:93388600-93394600	Enhancers	HUES48 Cell Line	embryonic stem cell
8	chr4:93389200-93396600	Weak transcription	HUES6 Cell Line	embryonic stem cell
9	chr4:93390600-93391800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
10	chr4:93390600-93392600	Weak transcription	HUES64 Cell Line	embryonic stem cell
11	chr4:93391800-93396800	Enhancers	iPS-15b Cell Line	embryonic stem cell
12	chr4:93392200-93392600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
13	chr4:93392200-93393000	Enhancers	H1 Cell Line	embryonic stem cell
14	chr4:93392400-93393000	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr4:93392600-93393200	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr4:93392600-93398400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
17	chr4:93392600-93399600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
18	chr4:93393000-93393800	Weak transcription	H1 Cell Line	embryonic stem cell
19	chr4:93393000-93397400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
20	chr4:93393200-93393600	Weak transcription	HUES64 Cell Line	embryonic stem cell
21	chr4:93393600-93394400	Enhancers	HUES64 Cell Line	embryonic stem cell
22	chr4:93393600-93394400	Enhancers	iPS-20b Cell Line	embryonic stem cell
23	chr4:93393600-93394600	Enhancers	iPS-18 Cell Line	embryonic stem cell
24	chr4:93393800-93394600	Enhancers	H1 Cell Line	embryonic stem cell
25	chr4:93394400-93396800	Weak transcription	HUES64 Cell Line	embryonic stem cell
26	chr4:93394400-93399400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
27	chr4:93394600-93395600	Weak transcription	HUES48 Cell Line	embryonic stem cell
28	chr4:93394600-93398000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
29	chr4:93394600-93398400	Weak transcription	H1 Cell Line	embryonic stem cell
30	chr4:93395400-93399800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr4:93395600-93395800	Enhancers	HUES48 Cell Line	embryonic stem cell
32	chr4:93395800-93396200	Weak transcription	HUES48 Cell Line	embryonic stem cell
33	chr4:93396200-93402200	Enhancers	HUES48 Cell Line	embryonic stem cell
34	chr4:93396600-93397400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
35	chr4:93396600-93400200	Enhancers	HUES6 Cell Line	embryonic stem cell
36	chr4:93396800-93397000	Enhancers	HUES64 Cell Line	embryonic stem cell
37	chr4:93396800-93398600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
38	chr4:93397000-93397400	Weak transcription	HUES64 Cell Line	embryonic stem cell
39	chr4:93397400-93398800	Enhancers	ES-I3 Cell Line	embryonic stem cell
40	chr4:93397400-93401400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr4:93397400-93402200	Enhancers	HUES64 Cell Line	embryonic stem cell
42	chr4:93398000-93398800	Enhancers	iPS-18 Cell Line	embryonic stem cell
43	chr4:93398400-93398800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
44	chr4:93398400-93398800	Enhancers	H1 Cell Line	embryonic stem cell
45	chr4:93398600-93402000	Enhancers	iPS-15b Cell Line	embryonic stem cell
46	chr4:93398800-93399200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
47	chr4:93398800-93399600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
48	chr4:93398800-93399600	Weak transcription	H1 Cell Line	embryonic stem cell
49	chr4:93398800-93401600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
50	chr4:93399200-93400400	Enhancers	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links